NCT02375802
Adipose-Derived Stromal Cells (ASC's) for Pressure Ulcers
Enrolling by Invitation
PHASE1Ages 18+InterventionalTreatmentMayo ClinicInvestigator-initiated
~12 participants
Updated 2026-01-14 on ClinicalTrials.gov
What's tested:Adipose-derived stromal cells
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Free of wound infection
Measured over one week
Conditions
Where it's being run
1 sites across 1 statesFlorida1
Study leadership
- Houssam Farres, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Males and females
Stage III pressure ulcers measuring 5 cc - 36 cc in volume (as measured by filling the wound with Normal Saline).
Inpatient or outpatient treatment of pressure ulcers
Diabetic Foot Ulcer Stage 1 or 2 of any size
Co-morbidities may include:
Peripheral Vascular Disease (PVD)
Coronary Artery Disease (CAD)
Chronic Renal Disease (CRD)
Chronic Liver Disease (CLD)
Hypertension (HTN)
Diabetes
The ability of subjects to give appropriate consent or have an appropriate representative available to do so
The ability of subjects to return for weekly wound assessments
Exclusion
Patients with allergies to TISSEEL, Tegaderm, or silicon
Diabetics with poor glucose metabolic control (HbA1c \> 9)
Target wounds that are in close proximity to potential cancerous lesions
Patients who require Negative Pressure Wound Therapy (NPWT), limb amputation, or surgical intervention at the target wound at the time of screening
Wounds located on the face
Patients with Stage 5 or 6 Peripheral Vascular disease (specifically, wounds that are caused by peripheral vascular disease such as leg ulcers)
Wounds caused by diabetes mellitus (diabetic foot ulcers).
BMI of \<16 Clinical signs of critical colonization or local infection
Prolonged (\> 6 months) use of steroids
Patients on active regimen of chemotherapy
Patients receiving radiation in proximity of wound
Decompensated chronic liver disease
What this trial measures
- Free of wound infectionone week
Symptoms include fever along with new or increasing pain, erythema, local warmth, swelling, purulent discharge, and/or malodor